Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL27639902 | 0.97 | MAOA (0.38) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL381401 | 0.77 | LMNA (0.37) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL8992272 | 0.74 | TAAR1 (0.37) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL28153554 | 0.74 | TRPA1 (0.41) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL8344991 | 0.69 | TRPA1 (0.36) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL9745989 | 0.67 | TSHR (0.38) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL24932018 | 0.67 | DPP4 (0.58) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL830 | 0.67 | — | — | |
| SCHEMBL5565016 | 0.67 | DPP4 (0.58) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL4916236 | 0.67 | DPP4 (0.58) | TAAR1SLC6A2MAOASLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023070009-A1 | SILYL ETHER DERIVATIVES OF POLYETHER POLYMERS | P2 SCIENCE, INC. (US) | 2023-04-27 | — | — | WO | claimed |
| EP-3998304-A2 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SmartKem Limited (GB) | 2022-05-18 | — | — | EP | claimed |
| US-11028386-B2 | Morpholino oligonucleotide manufacturing method | AJINOMOTO CO., INC. (JP) | 2021-06-08 | — | — | US | claimed |
| EP-2817355-B1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LTD (GB) | 2021-03-24 | — | — | EP | claimed |
| CN-106795186-B | Process for preparing morpholino oligonucleotides | 味之素株式会社 | 2021-03-02 | — | — | CN | claimed |
| EP-2817356-B1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LTD (GB) | 2021-02-17 | — | — | EP | claimed |
| EP-2817354-B1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LTD (GB) | 2021-01-13 | — | — | EP | claimed |
| US-10833274-B2 | Organic semiconductor compositions | SMARTKEM LIMITED (GB) | 2020-11-10 | — | — | US | claimed |
| EP-2817357-B1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LTD (GB) | 2020-11-04 | — | — | EP | claimed |
| EP-2817351-B1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LTD (GB) | 2020-08-26 | — | — | EP | claimed |
| EP-2817355-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | Smartkem Limited (GB) | 2014-12-31 | — | — | EP | claimed |
| EP-2817352-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | Smartkem Limited (GB) | 2014-12-31 | — | — | EP | claimed |
| WO-2013124687-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124685-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124684-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124688-A2 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124682-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124683-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| WO-2013124686-A1 | ORGANIC SEMICONDUCTOR COMPOSITIONS | SMARTKEM LIMITED (GB) | 2013-08-29 | — | — | WO | claimed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11028386-B2 | Morpholino oligonucleotide manufacturing method | DCLRE1B, RNGTT, RTCB | TAAR1 4592/4885SLC6A2 4368/4885MAOA 2979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.